Bimekizumab Safety in Patients with Psoriasis Achieving Complete Skin Clearance: 4-year Analysis from 5 Phase 3/3b Trials. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s757. https://doi.org/10.25251/v6wwxw80